BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Smirnova OV, Ostroukhova TY, Bogorad RL. JAK-STAT pathway in carcinogenesis: Is it relevant to cholangiocarcinoma progression. World J Gastroenterol 2007; 13(48): 6478-6491 [PMID: 18161917 DOI: 10.3748/wjg.v13.i48.6478]
URL: https://www.wjgnet.com/1007-9327/full/v13/i48/6478.htm
Number Citing Articles
1
C H Lee, C J Chang, Y J Lin, C N Yeh, M F Chen, S Y Hsieh. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinomaBritish Journal of Cancer 2009; 100(11): 1765 doi: 10.1038/sj.bjc.6605063
2
Ru-Nan Yu, Cheng-Juan Chen, Lei Shu, Yuan Yin, Zhi-Jian Wang, Tian-Tai Zhang, Da-Yong Zhang. Structure-based design and synthesis of pyrimidine-4,6-diamine derivatives as Janus kinase 3 inhibitorsBioorganic & Medicinal Chemistry 2019; 27(8): 1646 doi: 10.1016/j.bmc.2019.03.009
3
Nicole Cortez, Cecilia Villegas, Viviana Burgos, Jaime R. Cabrera-Pardo, Leandro Ortiz, Iván González-Chavarría, Vaderament-A. Nchiozem-Ngnitedem, Cristian Paz. Adjuvant Properties of Caffeic Acid in Cancer TreatmentInternational Journal of Molecular Sciences 2024; 25(14): 7631 doi: 10.3390/ijms25147631
4
Wenjun Du, Fuli Zhang, Pei Yan, Qingfu Lai, Junjian Li, Daqian Zhu, Lianbao Ye. Design, Synthesis, Activity Evaluation and Molecular Docking Study of Novel Janus kinase InhibitorsChemistrySelect 2021; 6(17): 4212 doi: 10.1002/slct.202100707
5
Baohong Liu, Xingxing Xiao, Ziqin Lin, Yongliang Lou, Lingling Zhao. PDGFRB is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancerCancer Biomarkers 2022; 34(2): 251 doi: 10.3233/CBM-210335
6
Po-Lin Kuo, Wen-Chiu Ni, Eing-Mei Tsai, Ya-Ling Hsu. Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cellsMolecular Cancer Therapeutics 2009; 8(5): 1328 doi: 10.1158/1535-7163.MCT-08-0914
7
Mesut Cihan Aydemir, İbrahim Yaman, Mehmet Akif Kilic. Membrane Receptor‐Mediated Disruption of Cellular Homeostasis: Changes in Intracellular Signaling Pathways Increase the Toxicity of Ochratoxin AMolecular Nutrition & Food Research 2024; 68(14) doi: 10.1002/mnfr.202300777
8
Celina Ang, Sonia Reichert, Randall F. Holcombe. The American Cancer Society's Oncology in Practice2018; : 117 doi: 10.1002/9781118592168.ch8
9
Teklie Mengie Ayele, Zelalem Tilahun Muche, Awgichew Behaile Teklemariam, Achenef Bogale, Endeshaw Chekol Abebe. Role of JAK2/STAT3 Signaling Pathway in the Tumorigenesis, Chemotherapy Resistance, and Treatment of Solid Tumors: A Systemic ReviewJournal of Inflammation Research 2022; : 1349 doi: 10.2147/JIR.S353489
10
Guan Lin, Zhang Xinhe, Tian Haoyu, Li Yiling. Aberrantly methylated-differentially expressed genes and related pathways in cholangiocarcinomaMedicine 2022; 101(25): e29379 doi: 10.1097/MD.0000000000029379
11
Bo Zhai, Xue-Ying Sun. Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinomaWorld Journal of Hepatology 2013; 5(7): 345-352 doi: 10.4254/wjh.v5.i7.345
12
Mark Carfagna, Ellen Cannady, Thomas Ryan, Jay Herman, Lew Truex, Kanchan Narwani, John Sullivan. Carcinogenicity assessment of baricitinib in Tg.rasH2 mice and Sprague-Dawley (Crl:CD) ratsRegulatory Toxicology and Pharmacology 2018; 92: 458 doi: 10.1016/j.yrtph.2017.11.020
13
HASAYA DOKDUANG, PUANGRAT YONGVANIT, NISANA NAMWAT, CHAWALIT PAIROJKUL, SAKKARN SANGKHAMANON, MIKA SAKURAI YAGETA, YOSHINORI MURAKAMI, WATCHARIN LOILOME. Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cellsOncology Reports 2016; 35(4): 2065 doi: 10.3892/or.2016.4584